Orphanin FQ acts as a supraspinal, but not a spinal, anti-opioid peptide

NeuroReport

Volumn 7, Issue 13, 1996, Pages 2125-2129

  Grisel, Judith E ^a   Mogil, Jeffrey S ^a   Belknap, John K ^a   Grandy, David K ^b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

LC132 receptor; Morphine; Nociception; Pain inhibition

Indexed keywords

MORPHINE; NOCICEPTIN; OPIATE RECEPTOR PEPTIDE; ORPHANIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; FEMALE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD;

EID: 0029804988     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199609020-00012     Document Type: Article

References (25)

1. Pasternak GW. Clin Neuropharmacol 16, 1-18 (1993).
2. Bunzow JR, Saez C, Mortrud M et al. FEBS Lett 347, 284-288 (1994).
3. Reinscheid RK, Nothacker H-P, Bourson A et al. Science 270, 792-794 (1995).
4. Zhang S and Yu L. J Biol Chem 270, 22772-22776 (1995).
5. Meunier J-C, Mollereau C, Toll L et al. Nature 377, 532-535 (1995).
6. Mogil JS, Grisel JE, Reinscheid RK et al. Neuroscience in press.
7. Yaksh TL and Rudy TA. Pain 4, 299-359 (1978).
8. Yaksh TL. Pain 11, 293 (1981).
9. Ben-Bassat J, Peretz E, Sulman FG. Arch int Pharmacodyn Ther 122, 434-447 (1959).
10. Laursen SE and Belknap JK. J Pharmacol Methods 16, 355-357 (1986).
11. Hylden JLK and Wilcox GL. Eur J Pharmacol 67, 313-316 (1980).
12. Fillingim RB and Maixner W. Pain Forum 4, 209-221 (1995).
13. Fang FG, Fields HL and Lee NM. J Pharmacol Exp Ther 238, 1039-1044 (1986).
14. Porreca F, Mosberg HI, Hurst R et al. J Pharmacol Exp Ther 230, 341-348 (1984).
15. Mogil JS, Sternberg WF, Marek P et al. Proc Natl Acad Sci USA 93, 3048-3055 (1996).
16. Brase DA, Loh HH and Way EL. J Pharmacol Exp Ther 201, 368-374 (1977).
17. Pick CG, Cheng J, Paul D et al. Brain Res 566 295-298 (1991).
18. Ho IK, Loh HH and Way EL. J Pharm Pharmacol 29, 583-584 (1977).
19. Rothamn RB. Synapse 12, 129-138 (1992).
20. Watkins LR, Suberg SN, Thurston CL et al. Brain Res 362, 308-317 (1986).
21. Urgan MO and Smith DJ. Neurosci Lett 174, 21-25 (1994).
22. Grisel JE, Watkins LR and Maier SF. Psychopharmacology, (in press).
23. Magnuson DSK, Sullivan AF, Simmonet G et al. Neuropeptides 16, 213-218 (1990).
24. Fujimoto JM, Arts KS, Rady JJ et al. Neuropharmacology 29, 609-617 (1990).
25. Wang XJ, Wang XH and Han JS. Brain Res 523, 5-10 (1990).